SINAGRA, Gianfranco
 Distribuzione geografica
Continente #
NA - Nord America 1.135
EU - Europa 396
AS - Asia 278
OC - Oceania 3
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 1.815
Nazione #
US - Stati Uniti d'America 1.130
CN - Cina 140
HK - Hong Kong 118
FI - Finlandia 86
DE - Germania 79
UA - Ucraina 76
IT - Italia 69
IE - Irlanda 40
GB - Regno Unito 24
IN - India 13
SE - Svezia 7
FR - Francia 6
BE - Belgio 5
CA - Canada 5
PH - Filippine 3
NZ - Nuova Zelanda 2
SG - Singapore 2
AU - Australia 1
BR - Brasile 1
ES - Italia 1
EU - Europa 1
MT - Malta 1
MU - Mauritius 1
NL - Olanda 1
RU - Federazione Russa 1
SA - Arabia Saudita 1
TR - Turchia 1
Totale 1.815
Città #
Ashburn 168
Fairfield 150
Hong Kong 118
Chandler 81
Woodbridge 81
Helsinki 74
Jacksonville 67
Seattle 62
Wilmington 54
Beijing 53
Houston 53
Princeton 48
Ann Arbor 43
Cambridge 42
Dublin 40
New York 39
Shanghai 19
Brescia 18
Nanjing 18
Washington 18
Dearborn 13
Lappeenranta 12
Pune 11
San Diego 11
Milan 10
Des Moines 9
Hebei 9
Jinan 8
Los Angeles 8
Frankfurt am Main 6
Novara 6
Shenyang 6
Brussels 5
Hangzhou 5
Kilburn 4
London 4
Quezon City 3
San Francisco 3
Strasbourg 3
Toronto 3
Verona 3
Calcinato 2
Castrezzato 2
Changsha 2
Chennai 2
Christchurch 2
Falkenstein 2
Gavardo 2
Guangzhou 2
Haikou 2
Halle 2
Jiaxing 2
Kunming 2
Lancaster 2
Lanzhou 2
Margherita di Savoia 2
Nanchang 2
Ningbo 2
Norwalk 2
Rome 2
Sandigliano 2
Singapore 2
Tianjin 2
Venice 2
West Jordan 2
Acton 1
Boardman 1
Buffalo 1
Cerignola 1
Chaoyang 1
Chicago 1
Chiswick 1
Cologne 1
Como 1
Crotone 1
Eindhoven 1
Esslingen am Neckar 1
Fuzhou 1
Hefei 1
Islington 1
Kocaeli 1
Markham 1
New Bedfont 1
Orange 1
Prescot 1
Redwood City 1
Reggio Nell'emilia 1
Richmond 1
Riyadh 1
Stoney Creek 1
Sydney 1
São Paulo 1
Vedano al Lambro 1
Villa d'Almè 1
Wandsworth 1
Zhengzhou 1
Totale 1.467
Nome #
Multiparametric prognostic scores in chronic heart failure with reduced ejection fraction: A long-term comparison 145
Prognostic role of β-blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score database 108
Deceptive meaning of oxygen uptake measured at the anaerobic threshold in patients with systolic heart failure and atrial fibrillation 102
Heart failure and anemia: Effects on prognostic variables 99
Prognostic role of atrial fibrillation in patients affected by chronic heart failure. Data from the MECKI score research group 95
Renal function and peak exercise oxygen consumption in chronic heart failure with reduced left ventricular ejection fraction 90
Sex Profile and Risk Assessment With Cardiopulmonary Exercise Testing in Heart Failure: Propensity Score Matching for Sex Selection Bias 90
The metabolic exercise test data combined with Cardiac And Kidney Indexes (MECKI) score and prognosis in heart failure. A validation study 90
ANMCO / FADOI / SIAARTI / SIC / SIMG / SIMI / SIMEU Consensus Document: The clinical-diagnostic and therapeutic pathway of the patient with acute heart failure from home to discharge from the Emergency Room / Emergency Department-Acceptance 63
Gender and age normalization and ventilation efficiency during exercise in heart failure with reduced ejection fraction 59
Exercise oscillatory ventilation and prognosis in heart failure patients with reduced and mid-range ejection fraction 51
Cardiovascular Death Risk in Recovered Mid-Range Ejection Fraction Heart Failure: Insights From Cardiopulmonary Exercise Test 49
Sacubitril/Valsartan: Updates and Clinical Evidence for a Disease-Modifying Approach 45
[Palliative inotrope therapy in advanced heart failure: organization and management] 39
Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19) 35
Machine learning for prediction of in-hospital mortality in coronavirus disease 2019 patients: results from an Italian multicenter study 34
Atrial signal amplitude predicts atrial high-rate episodes in implantable cardioverter defibrillator patients: Insights from a large database of remote monitoring trasmissions 33
Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era 32
[Position paper of the Italian Society of Cardiology: The renin-angiotensin-aldosterone system (RAAS) blockade in heart failure patients - Part I: From RAAS identification to clinical trials] 27
Implications of atrial fibrillation on the clinical course and outcomes of hospitalized COVID-19 patients: results of the Cardio-COVID-Italy multicentre study 26
Palliative care in the cardiac setting: A consensus document of the Italian Society of Cardiology (SIC) and Italian Society of Palliative Care (SICP) Joint Working Group 26
A national survey on prevalence of possible echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography: study design and patients characterization - the first insight from the AC-TIVE Study 26
Changes in Right Ventricular-to-Pulmonary Artery Coupling After Transcatheter Edge-to-Edge Repair in Secondary Mitral Regurgitation 24
Pulmonary embolism in patients with COVID-19: characteristics and outcomes in the Cardio-COVID Italy multicenter study 23
Revisiting a Prognosticating Algorithm from Cardiopulmonary Exercise Testing in Chronic Heart Failure (from the MECKI Score Population) 23
[Italian Society of Cardiology-Italian Society of Nephrology Consensus document: The cardio-renal interaction in the prevention and treatment of cardiovascular diseases - Part II: From preventive strategies to treatment of patients with cardio-renal damage] 22
[Position paper of the Italian Society of Cardiology: The renin-angiotensin-aldosterone system blockade in heart failure patients - Part II: Mechanistic effects of sacubitril/valsartan, placement in current guidelines and use in clinical practice] 20
The prognostic value of serial troponin measurements in patients admitted for COVID-19 19
Left ventricular wall thickness and severity of cardiac disease in women and men with transthyretin amyloidosis 19
[Italian Society of Cardiology-Italian Society of Nephrology Consensus document: The cardio-renal interaction in the prevention and treatment of cardiovascular diseases - Part I: From cardiovascular risk factors to the mechanisms of cardio-renal syndrome] 18
Impact of heart failure on the clinical course and outcomes of patients hospitalized for COVID-19. Results of the Cardio-COVID-Italy multicentre study 18
[Rationale and significance of the Italian Network for Cardiac Amyloidosis] 18
[Transcatheter devices for chronic heart failure: state of the art] 18
Determinants of the protective effect of glucocorticoids on mortality in hospitalized patients with COVID-19: Insights from the Cardio-COVID-Italy multicenter study 17
Correction to: SARS‑CoV‑2, myocardial injury and inflammation: insights from a large clinical and autopsy study 16
[2022 Update on myocarditis and pericarditis following COVID-19 vaccination. Expert Opinion of the Italian Society of Cardiology] 14
Value of the HFA-PEFF and H2 FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis 14
Right ventricular to pulmonary artery coupling and outcome in patients with cardiac amyloidosis 14
Evolution of tricuspid regurgitation after transcatheter edge-to-edge mitral valve repair for secondary mitral regurgitation and its impact on mortality 14
[Italian Society of Cardiology (SIC) Position paper: Technical, instrumental and standards of interpretation for electrocardiography, ambulatory electrocardiographic and blood pressure monitoring in telemedicine] 14
OLD AND NEW EQUATIONS FOR MAXIMAL HEART RATE PREDICTION IN PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION ON BETA-BLOCKERS TREATMENT. RESULTS FROM THE MECKI SCORE DATASET 13
[Myocarditis and pericarditis following mRNA COVID-19 vaccination. Expert opinion of the Italian Society of Cardiology] 12
Performance of risk stratification scores and role of comorbidities in older vs younger patients with pulmonary arterial hypertension 12
Prognostic impact of the updated 2018 HFA-ESC definition of advanced heart failure: results from the HELP-HF registry 12
The impact of UEFA Euro 2020 football championship on Takotsubo Syndrome: Results of a multicenter national registry 12
Pick Your Threshold: A Comparison Among Different Methods of Anaerobic Threshold Evaluation in Heart Failure Prognostic Assessment 11
Ischemic Etiology in Advanced Heart Failure: Insight from the HELP-HF Registry 11
Does moderate hyperkalemia influence survival in HF? Insights from the MECKI score data base 10
Effects of the COVID-19 pandemic on the formation of fellows in training in cardiology 9
SARS-CoV-2, myocardial injury and inflammation: insights from a large clinical and autopsy study 8
[Italian Society of Cardiology (SIC) Expert consensus document: Post-acute cardiovascular sequelae of SARS-CoV-2 infection] 8
Outcome and Morphofunctional Changes on Cardiac Magnetic Resonance in Patients With Acute Myocarditis Following mRNA COVID-19 Vaccination 7
Detailed Assessment of the "I Need Help" Criteria in Patients With Heart Failure: Insights From the HELP-HF Registry 6
Characteristics and outcomes of patients with tricuspid regurgitation and advanced heart failure 6
Unmasking the prevalence of amyloid cardiomyopathy in the real world: results from Phase 2 of the AC-TIVE study, an Italian nationwide survey 6
Prevalence and clinical outcomes of isolated or combined moderate to severe mitral and tricuspid regurgitation in patients with cardiac amyloidosis 5
Role of ejection fraction in patients at risk for advanced heart failure: insights from the HELP-HF registry 5
ECG/echo indexes in the diagnostic approach to amyloid cardiomyopathy: A head-to-head comparison from the AC-TIVE study 5
Real-world candidacy to mavacamten in a contemporary hypertrophic obstructive cardiomyopathy population 5
Renin-angiotensin-aldosterone system inhibition in patients affected by heart failure: efficacy, mechanistic effects and practical use of sacubitril/valsartan. Position Paper of the Italian Society of Cardiology 5
Clinical burden and predictors of non-cardiovascular mortality and morbidity in advanced heart failure 5
What about chronotropic incompetence in heart failure with mildly reduced ejection fraction? Clinical and prognostic implications from the Metabolic Exercise combined with Cardiac and Kidney Indexes score dataset 4
Clinical and prognostic implications of heart failure hospitalization in patients with advanced heart failure 4
Exploring the Prognostic Performance of MECKI Score in Heart Failure Patients with Non-Valvular Atrial Fibrillation Treated with Edoxaban 4
Guideline-directed medical therapy in severe heart failure with reduced ejection fraction: an analysis from the HELP-HF registry 3
Apoptosis, a useful marker in the management of hot-phase cardiomyopathy? 3
Frequency, characteristics and risk assessment of pulmonary arterial hypertension with a left heart disease phenotype 1
Management of hypertrophic cardiomyopathy 1
Glucagon-like peptide-1 receptor agonists use and associations with outcomes in heart failure and type 2 diabetes. Data from the Swedish Heart Failure and Swedish National Diabetes Registries 1
Totale 1.883
Categoria #
all - tutte 15.877
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.877


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201965 0 0 0 0 0 0 0 0 0 0 36 29
2019/2020364 35 9 11 29 18 33 45 34 40 55 33 22
2020/2021289 16 19 21 33 18 31 3 39 21 44 21 23
2021/2022167 7 13 7 10 4 8 1 13 9 22 26 47
2022/2023302 41 38 4 7 15 67 2 30 60 3 17 18
2023/2024612 40 16 76 65 47 123 46 29 138 27 5 0
Totale 1.883